Miguel Ángel Muñoz-Alía

7PUBLICATIONS
32CO-AUTHORS
NanomedicineCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2024
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.

|Jul 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Nir Drayman, Jennifer K DeMarco, Krysten A Jones

|Feb 03, 2021
MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.

Miguel Ángel Muñoz-Alía, Rebecca A Nace, Alexander Tischer

|Aug 28, 2020
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients.

Eugene S Bah, Rebecca A Nace, Kah Whye Peng

|Jul 31, 2019
Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins.

Miguel Angel Muñoz-Alía, Stephen J Russell

|Feb 22, 2018
Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses.

Miguel Ángel Muñoz-Alía, Claude P Muller, Stephen J Russell

Pageof 2

Frequent Collaborators

1 joint publications

Nir Drayman

1 joint publications

Jennifer K DeMarco

1 joint publications

Krysten A Jones

1 joint publications

Saara-Anne Azizi